Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors

We report four cases of successful treatment with certolizumab pegol (CZP) of rheumatoid arthritis (RA) patients with persistent inflamed residual mono- or oligosynovitis resistant to prior TNF-α inhibitors. Although the patients were in a moderate disease activity, a low activity, or a remission of...

Descripción completa

Detalles Bibliográficos
Autores principales: Koarada, Syuichi, Tsuboi, Masahiko, Komine, Mitsunori, Nakao, Yoshinobu, Tokuda, Yukiko, Ono, Yukihide, Tashiro, Satoko, Maruyama, Akihito, Ono, Nobuyuki, Ohta, Akihide, Tada, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584239/
https://www.ncbi.nlm.nih.gov/pubmed/26451269
http://dx.doi.org/10.1155/2015/348614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584239/
https://www.ncbi.nlm.nih.gov/pubmed/26451269
http://dx.doi.org/10.1155/2015/348614

Ejemplares similares